73 results
Page 3 of 4
8-K
EX-99.1
mfx4u9a7z0wf6sd61
10 Nov 22
Talaris Therapeutics Announces Third Quarter Financial Results and Corporate Update
7:12am
8-K
EX-99.1
6mu9s3
20 Oct 22
Talaris Therapeutics Provides Update on FREEDOM-1 Phase 3 Clinical Trial
7:12am
8-K
4e0 zn45i
13 Jun 22
Submission of Matters to a Vote of Security Holders
5:09pm
8-K
wsgc2mtbynptn9t0m2x
17 May 22
Talaris Therapeutics Announces Changes to Board of Directors
8:29am
DEFA14A
k0dndn4b7
29 Apr 22
Additional proxy soliciting materials
4:27pm
DEF 14A
iz79u3
29 Apr 22
Definitive proxy
4:24pm
10-K
puriokmk42315
17 Mar 22
Annual report
4:31pm
10-Q
it6ez2o8
14 Jun 21
Quarterly report
4:21pm
8-K
EX-3.1
da595a3t60grg yc
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
8-K
EX-3.2
ob5yppx
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
424B4
r03rrx
10 May 21
Prospectus supplement with pricing info
4:20pm
S-1/A
EX-10.2
12z24k1coplbis a8
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-1.1
bdwyzm rh3ck
3 May 21
IPO registration (amended)
6:07am